Yisaipu, Biosimilar of Enbrel, Will be Available as Pre-filled Syringe in China
Yisaipu, a biosimilar of Enbrel (etanercept), has been approved in China as a pre-filled syringe to treat ankylosing spondylitis, among other conditions, announced the treatment’s developer, Sunshine Guojian Pharmaceutical, a subsidiary of 3SBio. Because lack of adherence to treatment may be a cause for repeated disease onset, this new…